WG
KIN

Winton Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Winton Group’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,750
Closed -$85K – 1596
2020
Q3 		$85K Sell
19,750
-3,609
-15% -$15.1K ﹤0.01% 1418
2020
Q2 		$105K Sell
23,359
-10,704
-31% -$47.8K ﹤0.01% 1399
2020
Q1 		$136K Sell
34,063
-9,495
-22% -$80.6K ﹤0.01% 1296
2019
Q4 		$369K Sell
43,558
-14,479
-25% -$113K 0.01% 1324
2019
Q3 		$398K Buy
+58,037
New +$426K ﹤0.01% 1166
2019
Q2 		– Sell
-18,652
Closed -$171K – 1332
2019
Q1 		$171K Buy
+18,652
New +$189K ﹤0.01% 984

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winton Group's KIN Position: Q4 2020 in Review

Winton Group sold out of Kindred Biosciences, Inc. (KIN) in Q4 2020, closing a stake of 19,750 shares — an estimated $85K sold.

Winton Group first reported a position in KIN in Q1 2019 and held it in 6 quarters. The position peaked at $398K in Q3 2019. 82 funds tracked by Wall St. Rank hold KIN as of Q4 2020.

  • Winton Group reported no remaining Kindred Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Winton Group sold 19,750 Kindred Biosciences, Inc. shares in Q4 2020, an estimated $85K.
  • Winton Group first reported a position in Kindred Biosciences, Inc. in Q1 2019 and held it in 6 quarters.
  • Winton Group's Kindred Biosciences, Inc. position peaked at $398K in Q3 2019.
  • 82 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.